CROI 2017 Program and Information

Program and Agenda

716LB HUMAN ANDMOUSE HEMATOPOIETIC STEMCELLS ARE A DEPOT FOR DORMANTM. TUBERCULOSIS Julia Tornack 1 , Stephen Reece 1 , Wolfgang Bauer 2 , Alexis Vogelzang 1 , Silke Bandermann 1 , Ulrike Zedler 1 , Georg Stingl 2 , Stefan Kaufmann 1 , Fritz Melchers 1 1 Max Planck Inst for Infection Bio, Berlin, Germany, 2 Med Univ of Vienna, Vienna, Austria Poster P-P3 TB TREATMENT, OUTCOMES, AND MORTALITY Poster Hall - 4 EF 2:30 PM - 4:00 PM 717 RISK FACTORS FOR DEATH IN ADVANCED HIV-INFECTED ADULTS IN AN EMPIRIC TB THERAPY TRIAL Gregory Bisson 1 , Ritesh Ramchandani 2 , Sachiko Miyahara 2 , Xin Sun 2 , Jing Bao 3 , Amita Gupta 4 , Mina C. Hosseinipour 5 , Johnstone Kumwenda 6 , for the Adult AIDS Clinical Trials Group A5274 (REMEMBER) Study Team 1 Univ of Pennsylvania, Philadelphia, PA, USA, 2 Harvard Univ, Boston, MA, USA, 3 NIH, Bethesda, MD, USA, 4 Johns Hopkins Univ, Baltimore, MD, USA, 5 Univ of North Carolina Proj–Malawi, Lilongwe, Malawi, 6 Malawi Coll of Med–Johns Hopkins Univ Rsr Proj, Blantyre, Malawi 718 DOES TIME TO ART INITIATION IMPACT EARLY RESPONSES TO DR-TB TREATMENT? Erika K. Mohr 1 , Johnny Daniels 1 , Odelia Muller 1 , Bongani Chabalala 1 , Jennifer Hughes 1 , Virginia de Azevedo 2 , Amir Shroufi 3 , Sarah Jane Steele 3 , Gabriella Ferlazzo 3 , Laura Trivino Duran 1 1 MSF, Khayelitsha, Cape Town, South Africa, 2 City of Cape Town Dept of Hlth, Cape Town, South Africa, 3 MSF, Cape Town, South Africa 719 HIV-RELATED TB TREATMENT INTERMITTENCY IN THE CONTINUATION PHASE ANDMORTALITY Brenda Crabtree-Ramírez 1 , Cathy Jenkins 2 , Bryan E. Shepherd 2 , Karu Jayathilake 2 , Valdilea Veloso 3 , Eduardo Gotuzzo 4 , Claudia P. Cortes 5 , Denis Padgett 6 , Catherine McGowan 2 , Timothy R. Sterling 2 1 Inst Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico, Mexico, 2 Vanderbilt Univ, Nashville, TN, USA, 3 Oswaldo Cruz Fndn–Fiocruz, Rio de Janeiro, Brazil, 4 Univ Peruana Cayetano Heredia, Lima, Peru, 5 Univ of Chile, Santiago, Chile, 6 Hosp Seguro Social, Tegucigalpa, Honduras 720 IMPACT OF INH ADHERENCE ON TB INCIDENCE ANDMORTALITY BYWEEK 96 IN ACTG 5274 TRIAL Amita Gupta 1 , Xin Sun 2 , Sachiko Miyahara 2 , Mitch Matoga 3 , Deborah Langat 4 , Cynthia Riviere 5 , Gregory Bisson 6 , Johnstone Kumwenda 7 , Mina C. Hosseinipour 3 , for the ACTG A5274/REMEMBER Study Team 1 Johns Hopkins Univ, Baltimore, MD, USA, 2 Harvard Univ, Boston, MA, USA, 3 Univ of North Carolina Proj–Malawi, Lilongwe, Malawi, 4 KEMRI/Walter Reed Proj, Kericho, Kenya, 5 Les Cntrs GHESKIO, Port-Au-Prince, Haiti, 6 Univ of Pennsylvania, Philadelphia, PA, USA, 7 Malawi Coll of Med–Johns Hopkins Univ Rsr Proj, Blantyre, Malawi

Poster Sessions • Tuesday

721 WITHDRAWN

CROI 2017 105